Patent details

Basic Information

Publication number:

EP0522138

PCT Application Number:

PCT/FR/92/00066

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP929048528

PCT Publication Number:

WO/92/01300

First applicant's nationality:

Translation Language:

EPO Publication Language:

French

English Title of Invention:

INFLUENZA VIRUS VACCINE COMPOSITION AND CONTAINING INFLUENZA VIRUS CORE AS AN ADDITIVE HAVING A SYNERGISTIC EFFECT

French Title of Invention:

COMPOSITION VACCINALE CONTRE LA GRIPPE CONTENANT COMME ADDITIF DU CORE DE VIRUS GRIPPAL A EFFET SYNERGIQUE

German Title of Invention:

INFLUENZAIMPFSTOFF, DER ALS SINERGISTISCHER ZUSATZMITTEL INFLUENZAVIRUSINNENKÖRPER ENTHÄLT

SPC Number:

Dates

Filing date:

24/01/1992

Grant date:

19/03/2003

EP Publication Date:

19/03/2003

PCT Publication Date:

06/08/1992

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/01/1993

EP B1 Publication Date:

19/03/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/01/2004

Expiration date:

24/01/2012

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/02/2005

 

 

Name:

Sanofi Pasteur

Address:

2, avenue Pont Pasteur, 69367 Lyon Cedex 07, France (FR)

Inventor

1

Name:

MEIGNIER Bernard

Address:

France (FR)

2

Name:

MOSTE-DESHAIRS Catherine

Address:

France (FR)

Priority

Priority Number:

9100806

Priority Date:

24/01/1991

Priority Country:

France (FR)

Classification

Main IPC Class:

C07K 14/10;

Filing date	Document type	Number of pages